BACKGROUND & AIMS: As the risk of esophageal adenocarcinoma (EAC) and mortality in
patients with Barrett's esophagus (BE) are important determinants of the potential yield and …

OBJECTIVES: Barrett's esophagus (BE) is associated with an increased risk of developing
esophageal adenocarcinoma (EAC). Patients with a known diagnosis of BE are usually …

METHODS A hospital-based case-control study was performed in which 91 cases with EAC
and 244 controls with histologically confirmed BE (> 2 cm) with no dysplasia or low-grade …

Since the early 1970s, the incidence of esophageal adenocarcinoma (EA) has increased
dramatically in most Western populations while the incidence of esophageal squamous cell …

Background Accurate population-based data are needed on the incidence of esophageal
adenocarcinoma and high-grade dysplasia among patients with Barrett's esophagus …

OBJECTIVES: Patients with Barrett's esophagus (BE) have an increased risk of developing
esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for …

Background & Aims Although patients with Barrett's esophagus commonly undergo
endoscopic surveillance, its effectiveness in reducing mortality from esophageal …

BACKGROUND & AIMS: Understanding the causes of death in people with Barrett's
esophagus (BE) could guide evidence-based practice in the follow-up of these patients …

Background Barrett's esophagus (BE) is a premalignant lesion that predisposes to
esophageal adenocarcinoma. However, the reported incidence of esophageal …

BACKGROUND: Patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD)
are at a high risk for developing esophageal adenocarcinoma. However, the reported rate of …